DIGNITANA AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.12 SEK | -1.40% |
|
+35.90% | -2.75% |
| 05-23 | Dignitana AB Approves the Election of Fredrik Lindgren and Hope S. Rugo as Board Members | CI |
| 05-23 | Dignitana AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Presenter SpeechMark Siöstedt (Analysts)Hello, and welcome to today's event with Dignitana. My...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Dignitana AB is a Sweden-based medical technology company. It develops, manufactures and markets a medical device primarily used for scalp cooling in order to eliminate or reduce chemotherapy induced hair loss. The Company focuses on the product DigniCap, which counteracts hair loss during chemotherapy. The product is a cold cap, which when put on the patientâs head, lowers the temperature of the scalp. The low temperature reduces perfusion, delivery of blood and metabolism. The reduced blood flow results in a smaller amount of chemotherapy available for uptake in the cells, while the decreased temperature results in less absorption and reduced effects of chemotherapy. These factors together reduce the risk of hair loss. The DigniCap scalp cooling system is patented in Europe, Japan and the United States. It has a subsidiary BrainCool AB, which focuses on producing different models of brain cooling for stroke and cardiac arrest patients.
Calendar
21/08/2024
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.75% | 14.37M | |
| +75.56% | 12.56B | |
| -23.35% | 7.47B | |
| +8.51% | 6.75B | |
| +14.95% | 5.5B | |
| -15.51% | 4.94B | |
| +30.59% | 4.66B | |
| -25.47% | 3.75B | |
| -22.61% | 2.92B | |
| +49.50% | 2.4B |
- Stock Market
- Equities
- DIGN Stock
- News Dignitana AB
- Transcript : Dignitana AB (publ.) - Special Call
